NASDAQ:UPC - Nasdaq - KYG9442G1385 - Common Stock - Currency: USD
NASDAQ:UPC (8/14/2025, 10:51:55 AM)
3.58
-0.82 (-18.64%)
The current stock price of UPC is 3.58 USD. In the past month the price increased by 18.6%. In the past year, price decreased by -99.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 41.59 | 636.59B | ||
JNJ | JOHNSON & JOHNSON | 17.41 | 419.27B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 17.6 | 242.30B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.75 | 235.65B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 12.88 | 224.26B | ||
MRK | MERCK & CO. INC. | 10.77 | 208.26B | ||
PFE | PFIZER INC | 7.34 | 141.51B | ||
SNY | SANOFI-ADR | 10.93 | 118.66B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 7.04 | 96.45B | ||
GSK | GSK PLC-SPON ADR | 8.49 | 78.28B | ||
ZTS | ZOETIS INC | 24.56 | 68.01B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 49.33 | 46.74B |
Universe Pharmaceuticals Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
UNIVERSE PHARMACEUTICALS INC
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone
Ji'an JIANGXI CN
Employees: 225
Phone: 867968403309
The current stock price of UPC is 3.58 USD. The price decreased by -18.64% in the last trading session.
The exchange symbol of UNIVERSE PHARMACEUTICALS INC is UPC and it is listed on the Nasdaq exchange.
UPC stock is listed on the Nasdaq exchange.
UNIVERSE PHARMACEUTICALS INC (UPC) has a market capitalization of 2.00M USD. This makes UPC a Nano Cap stock.
UNIVERSE PHARMACEUTICALS INC (UPC) currently has 225 employees.
UNIVERSE PHARMACEUTICALS INC (UPC) has a support level at 3.37 and a resistance level at 4.55. Check the full technical report for a detailed analysis of UPC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UPC does not pay a dividend.
The PE ratio for UNIVERSE PHARMACEUTICALS INC (UPC) is 0.02. This is based on the reported non-GAAP earnings per share of 191.57 and the current share price of 3.58 USD. Check the full fundamental report for a full analysis of the valuation metrics for UPC.
The outstanding short interest for UNIVERSE PHARMACEUTICALS INC (UPC) is 5.41% of its float. Check the ownership tab for more information on the UPC short interest.
ChartMill assigns a technical rating of 2 / 10 to UPC. When comparing the yearly performance of all stocks, UPC is a bad performer in the overall market: 98.36% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to UPC. While UPC seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months UPC reported a non-GAAP Earnings per Share(EPS) of 191.57. The EPS increased by 106.13% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.65% | ||
ROA | 1.35% | ||
ROE | 1.97% | ||
Debt/Equity | 0.04 |